← Leaderboards
Charles A O'Brien
Univ Of Arkansas For Med Scis
$15,608,722
Attributed
$16,563,811
Total exposure
13
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$35,007,582 · 13
VA$0 · 1
By mechanism
P20$23,630,197 · 5
R01$8,327,464 · 3
P01$3,034,921 · 4
R13$15,000 · 1
I01$0 · 1
Top collaborators
- Maria Jose Almeida5 shared
Most similar at Univ Of Arkansas For Med Scis
Same institution · by research overlap
- Ha-Neui Kim$2,647,044
- Maria Jose Almeida$5,489,226
- Jesus Delgado-Calle$3,731,034
- Shoshana Bartell$169,605
- Brent J F Hill$620,493
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularBoneCellsSkeletalBone RemodelingOsteoporosisOsteoblastsProductionGenesBone MassBaseOsteocytesOsteoclastsSkeletonBone ResorptionLigandsCell TypeResearch PersonnelFundingBone LossIn VivoAllelesAgingPlay
Grant awards (80)
Center for Musculoskeletal Disease Research (CMDR)$2,295,000
P20 · FY2025 · GM · contact PI
Administrative Core$549,862
P20 · FY2025 · GM · contact PI
Different consequences of cellular aging in cortical versus cancellous bone- Resubmission$375,899
R01 · FY2025 · AG
Osteocyte Control of Bone Remodeling$300,960
R01 · FY2025 · AR · contact PI
Center for Musculoskeletal Disease Research (CMDR)$2,295,000
P20 · FY2024 · GM · contact PI
Administrative Core$619,271
P20 · FY2024 · GM · contact PI
Different consequences of cellular aging in cortical versus cancellous bone- Resubmission$383,570
R01 · FY2024 · AG
Osteocyte Control of Bone Remodeling$324,368
R01 · FY2024 · AR · contact PI
Center for Musculoskeletal Disease Research (CMDR)$250,000
P20 · FY2024 · GM · contact PI
2024 Bones and Teeth Gordon Research Conference and Gordon Research Seminar$15,000
R13 · FY2024 · AR · contact PI
Center for Musculoskeletal Disease Research (CMDR)$2,295,000
P20 · FY2023 · GM · contact PI
Administrative Core$588,391
P20 · FY2023 · GM · contact PI
Different consequences of cellular aging in cortical versus cancellous bone- Resubmission$383,570
R01 · FY2023 · AG
Osteocyte Control of Bone Remodeling$334,400
R01 · FY2023 · AR · contact PI
Center for Musculoskeletal Disease Research (CMDR)$2,274,413
P20 · FY2022 · GM · contact PI
Administrative Core$511,731
P20 · FY2022 · GM · contact PI
Different consequences of cellular aging in cortical versus cancellous bone- Resubmission$383,570
R01 · FY2022 · AG
Osteocyte Control of Bone Remodeling$334,400
R01 · FY2022 · AR · contact PI
Genetic Models$196,821
P20 · FY2022 · GM · contact PI
Molecular mechanisms of glucocorticoid-induced bone loss$0
I01 · FY2022 · VA · contact PI
Center for Musculoskeletal Disease Research (CMDR)$2,274,413
P20 · FY2021 · GM · contact PI
Administrative Core$495,123
P20 · FY2021 · GM · contact PI
Different consequences of cellular aging in cortical versus cancellous bone- Resubmission$383,570
R01 · FY2021 · AG
Genetic Models$190,435
P20 · FY2021 · GM · contact PI
Molecular mechanisms of glucocorticoid-induced bone loss$0
I01 · FY2021 · VA · contact PI
Center for Musculoskeletal Disease Research (CMDR)$2,268,208
P20 · FY2020 · GM · contact PI
Administrative Core$494,030
P20 · FY2020 · GM · contact PI
Genetic Models$190,010
P20 · FY2020 · GM · contact PI
Molecular mechanisms of glucocorticoid-induced bone loss$0
I01 · FY2020 · VA · contact PI
Center for Musculoskeletal Disease Research (CMDR)$2,253,315
P20 · FY2019 · GM · contact PI
Administrative Core$489,396
P20 · FY2019 · GM · contact PI
Osteocyte Control of Bone Remodeling$327,800
R01 · FY2019 · AR · contact PI
Genetic Models$188,230
P20 · FY2019 · GM · contact PI
Molecular mechanisms of glucocorticoid-induced bone loss$0
I01 · FY2019 · VA · contact PI
Center for Musculoskeletal Disease Research (CMDR)$2,238,422
P20 · FY2018 · GM · contact PI
Administrative Core$486,146
P20 · FY2018 · GM · contact PI
Osteocyte Control of Bone Remodeling$378,793
R01 · FY2018 · AR · contact PI
Genetic Models$186,980
P20 · FY2018 · GM · contact PI
Osteocyte Control of Bone Remodeling$378,793
R01 · FY2017 · AR · contact PI
RANKL and lymphocyte-mediated bone loss$0
I01 · FY2017 · VA · contact PI
Osteocyte Control of Bone Remodeling$327,800
R01 · FY2016 · AR · contact PI
MECHANISMS OF GLUCOCORTICOID ACTION ON OSTEOCYTES: OXIDATIVE STRESS VS AUTOPHAGY$294,361
P01 · FY2016 · AG · contact PI
TRANSGENIC MOUSE CORE$160,215
P01 · FY2016 · AG · contact PI
Research Supplement to Promote Diversity in Health-related Research$32,229
R01 · FY2016 · AR · contact PI
RANKL and lymphocyte-mediated bone loss$0
I01 · FY2016 · VA · contact PI
Osteocyte Control of Bone Remodeling$327,800
R01 · FY2015 · AR · contact PI
MECHANISMS OF GLUCOCORTICOID ACTION ON OSTEOCYTES: OXIDATIVE STRESS VS AUTOPHAGY$285,529
P01 · FY2015 · AG · contact PI
TRANSGENIC MOUSE CORE$155,410
P01 · FY2015 · AG · contact PI
RANKL and lymphocyte-mediated bone loss$0
I01 · FY2015 · VA · contact PI
MECHANISMS OF GLUCOCORTICOID ACTION ON OSTEOCYTES: OXIDATIVE STRESS VS AUTOPHAGY$294,361
P01 · FY2014 · AG · contact PI
TRANSGENIC MOUSE CORE$160,215
P01 · FY2014 · AG · contact PI
RANKL and lymphocyte-mediated bone loss$0
I01 · FY2014 · VA · contact PI
MECHANISMS OF GLUCOCORTICOID ACTION ON OSTEOCYTES: OXIDATIVE STRESS VS AUTOPHAGY$278,170
P01 · FY2013 · AG · contact PI
TRANSGENIC MOUSE CORE$151,404
P01 · FY2013 · AG · contact PI
Molecular Control of RANKL Gene Expression$303,178
R01 · FY2012 · AR · contact PI
MECHANISMS OF GLUCOCORTICOID ACTION ON OSTEOCYTES: OXIDATIVE STRESS VS AUTOPHAGY$294,195
P01 · FY2012 · AG · contact PI
TRANSGENIC MOUSE CORE$160,124
P01 · FY2012 · AG · contact PI
RANKL and Inflammation-associated Bone Loss$0
I01 · FY2012 · VA · contact PI
Molecular Control of RANKL Gene Expression$303,178
R01 · FY2011 · AR · contact PI
RANKL and Inflammation-associated Bone Loss$0
I01 · FY2011 · VA · contact PI
RANKL and Inflammation-associated Bone Loss$0
I01 · FY2011 · VA · contact PI
Molecular Control of RANKL Gene Expression$315,810
R01 · FY2010 · AR · contact PI
TRANSGENIC MOUSE CORE$182,850
P01 · FY2010 · AG · contact PI
Molecular Control of RANKL Gene Expression$319,000
R01 · FY2009 · AR · contact PI
TRANSGENIC MOUSE CORE$179,368
P01 · FY2009 · AG · contact PI
RANKL and Inflammation-associated Bone Loss$0
I01 · FY2009 · VA · contact PI
Molecular Control of RANKL Gene Expression$316,228
R01 · FY2008 · AR · contact PI
TRANSGENIC MOUSE CORE$176,469
P01 · FY2008 · AG · contact PI
MOLECULAR CONTROL OF RANKL GENE EXPRESSION$241,010
R01 · FY2007 · AR · contact PI
TRANSGENIC MOUSE CORE$153,893
P01 · FY2007 · AG · contact PI
MOLECULAR CONTROL OF RANKL GENE EXPRESSION$248,207
R01 · FY2006 · AR · contact PI
TRANSGENIC MOUSE CORE$108,357
P01 · FY2006 · AG · contact PI
MOLECULAR CONTROL OF RANKL GENE EXPRESSION$275,480
R01 · FY2005 · AR
MOLECULAR CONTROL OF RANKL GENE EXPRESSION$275,480
R01 · FY2004 · AR
MOLECULAR CONTROL OF RANKL GENE EXPRESSION$275,480
R01 · FY2003 · AR
IN VIVO REGULATION OF IL6 AND IL6R GENE EXPRESSION$129,095
R01 · FY2002 · AR
MOLECULAR LINKAGE BETWEEN OSTEOBLASTO/OSTEOCLASTOGENESIS$0
P01 · FY2002 · AG
IN VIVO REGULATION OF IL6 AND IL6R GENE EXPRESSION$176,446
R01 · FY2001 · AR
MOLECULAR LINKAGE BETWEEN OSTEOBLASTO/OSTEOCLASTOGENESIS$0
P01 · FY2001 · AG
IN VIVO REGULATION OF IL6 AND IL6R GENE EXPRESSION$171,350
R01 · FY2000 · AR